Rocket


News + Filings
Transactions





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Lawton Alison Frances Create: Alert

All | News | Filings
Date FiledTypeDescription
06/30/2023 4 Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 1,950,000 options to buy @ $0.3, valued at $585k
06/30/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/27/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/10/2022 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/09/2021 4 Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 40,000 options to buy @ $6.8, valued at $272k
06/03/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
06/02/2021 4 Form 4 - Statement of changes in beneficial ownership of securities:
12/23/2020 4 Lawton Alison Frances (Director) has filed a Form 4 on Magenta Therapeutics, Inc.
Txns: Granted 36,377 options to buy @ $7.85, valued at $285.6k
12/23/2020 3 Lawton Alison Frances (Director) has filed a Form 3 on Magenta Therapeutics, Inc.
12/17/2020 4 Lawton Alison Frances (Director) has filed a Form 4 on Aeglea BioTherapeutics, Inc.
Txns: Granted 47,200 options to buy @ $9.09, valued at $429k
12/17/2020 3 Lawton Alison Frances (Director) has filed a Form 3 on Aeglea BioTherapeutics, Inc.
10/06/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/06/2020 3 Form 3 - Initial statement of beneficial ownership of securities:
04/17/2020 4 Lawton Alison Frances (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 118,500 options to buy @ $6, valued at $711k
03/03/2020 4 Form 4 - Statement of changes in beneficial ownership of securities:
11/18/2019 4 Lawton Alison Frances (See Remarks) has filed a Form 4 on Kaleido Biosciences, Inc.
Txns: Granted 150,000 options to buy @ $6.56, valued at $984k
06/25/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
03/04/2019 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/27/2019 3 Form 3 - Initial statement of beneficial ownership of securities:
06/15/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
03/01/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
01/04/2017 4 Form 4 - Statement of changes in beneficial ownership of securities
06/16/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
05/12/2016 4 Form 4 - Statement of changes in beneficial ownership of securities
03/15/2016 4 Lawton Alison Frances (Director) has filed a Form 4 on CoLucid Pharmaceuticals, Inc.
Txns: Granted 1,420 options to buy @ $6.54, valued at $9.3k
03/15/2016 3 Lawton Alison Frances (Director) has filed a Form 3 on CoLucid Pharmaceuticals, Inc.
06/11/2013 4 Lawton Alison Frances (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Exercised 1,347 restricted stock units @ $0
06/11/2013 4 Lawton Alison Frances (COO) has filed a Form 4 on OvaScience, Inc.
06/06/2013 4 LAWTON ALISON FRANCIS (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 12,500 options to buy @ $9.34, valued at $116.8k
Granted 6,507 options to buy @ $9.34, valued at $60.8k
03/11/2013 4 LAWTON ALISON FRANCIS (COO) has filed a Form 4 on OvaScience, Inc.
11/27/2012 4 LAWTON ALISON FRANCIS (Director) has filed a Form 4 on Verastem, Inc.
Txns: Granted 25,000 options to buy @ $6.47, valued at $161.8k
11/27/2012 3 LAWTON ALISON FRANCIS (Director) has filed a Form 3 on Verastem, Inc.
06/11/2012 4 LAWTON ALISON FRANCIS (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Granted 372 shares @ $0
Granted 9,367 options to buy @ $41.2, valued at $385.9k
Granted 1,347 restricted stock units @ $0
02/17/2012 4 LAWTON ALISON FRANCIS (Director) has filed a Form 4 on CUBIST PHARMACEUTICALS INC
Txns: Granted 10,842 options to buy @ $40.59, valued at $440.1k

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy